Study details
Enrolling now
Angiotensin-(1-7) Cardiovascular Effects in Aging
Milton S. Hershey Medical Center
NCT IDNCT05301192ClinicalTrials.gov data as of Apr 2026
Phase
EARLY_PHASE1
Target enrollment
26
Study length
about 4.1 years
Ages
65–80
Locations
1 site in PA
What this study is about
Researchers are testing whether angiotensin-(1-7), a protective hormone, can reduce cardiovascular sympathetic outflow and blood pressure. The trial will compare angiotensin-(1-7) to saline in older healthy adults.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Angiotensin-(1-7)
- 2.Take Saline
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
angiotensin II
Endpoints
Secondary: Change in Heart Rate, Change in Heart Rate Variability, Change in Systolic and Diastolic Blood Pressure